谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 42 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Ibrutinib As First-Line Therapy for Mantle Cell Lymphoma: a Multicenter, Real-World UK Study
Ann Tivey,Rohan Shotton,Toby A. Eyre,David Lewis,Louise Stanton, Rebecca Allchin,Harriet Walter,Fiona Miall,Rui Zhao,Anna Santarsieri,Rory Mcculloch,Mark Bishton,Amy Beech,Victoria Willimott, Nicole Fowler, Claudia Bedford, Jack Goddard, Sam Protheroe,Angharad Everden,David Tucker,Josh Wright, Vasavi Dukka, Miriam Reeve,Shankara Paneesha,Mahesh Prahladan,Andrew Hodson,Iman Qureshi, Manasvi Koppana, Mary Owen,Kushani Ediriwickrema,Helen Marr, Jamie Wilson,Jonathan Lambert,David Wrench,Claire Burney,Chloe Knott,Georgina Talbot,Adam Gibb, Angela Lord, Barry Jackson,Simon Stern, Taylor Sutton, Amy Webb, Marketa Wilson, Nicky Thomas,Jane Norman,Elizabeth Davies,Lisa Lowry,Jamie Maddox,Neil Phillips,Nicola Crosbie, Marcin Flont, Emma Nga,Andres Virchis, Raisa Guerrero Camacho, Wunna Swe,Arvind Pillai, Clare Rees, James Bailey, Steve Jones, Susan Smith,Faye Sharpley,Catherine Hildyard,Sajir Mohamedbhai, Toby Nicholson, Simon Moule,Anshuman Chaturvedi,Kim Linton
BLOOD ADVANCESno. 5 (2024): 1209-1219
引用1浏览0WOS引用
1
0
P1141: IBRUTINIB AND RITUXIMAB AS FIRST LINE THERAPY FOR MANTLE CELL LYMPHOMA: A MULTICENTRE, REAL-WORLD UK STUDY
A. Tivey,R. Shotton,T. A. Eyre,D. Lewis,N. Crosbie, E. Nga, R. Guerrero Camacho, W. Swe,H. Marr, C. Rees,S. Moule, T. Sutton,D. Wrench, N. Thomas,M. Wilson, J. Bailey,M. Prahladan,A. Hodson, M. Koppana, S. Smith, S. Jones,F. Miall,J. Norman,E. Davies, C. Hildyard,L. Lowry,S. Paneesha,I. Qureshi,A. Beech,C. Bedford, A. Everden,D. Tucker,J. Wright, J. Goddard, T. Nicholson, J. Wilson, A. Lord,B. Jackson, M. Flont,A. Gibb,K. Linton
HemaSphere（2022）
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 42

#Citation: 341

H-Index: 10

G-Index: 18

Sociability: 6

Diversity: 2

Activity: 3

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn